These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32039724)

  • 41. Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero.
    Rø TB; Ludvigsen HV; Carlsen SM; Vanky E
    Scand J Clin Lab Invest; 2012 Nov; 72(7):570-5. PubMed ID: 22935043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study.
    Diav-Citrin O; Steinmetz-Shoob S; Shechtman S; Ornoy A
    Reprod Toxicol; 2018 Sep; 80():85-91. PubMed ID: 29857030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.
    Lautatzis ME; Goulis DG; Vrontakis M
    Metabolism; 2013 Nov; 62(11):1522-34. PubMed ID: 23886298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel method to demonstrate that pregnant women with polycystic ovary syndrome hyper-expose their fetus to androgens as a possible stepping stone for the developmental theory of PCOS. A pilot study.
    Homburg R; Gudi A; Shah A; M Layton A
    Reprod Biol Endocrinol; 2017 Aug; 15(1):61. PubMed ID: 28789693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome - an epi-analysis.
    Vanky E; DE Zegher F; Díaz M; Ibáñez L; Carlsen SM
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1460-4. PubMed ID: 23006146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome.
    Caanen MR; Kuijper EA; Hompes PG; Kushnir MM; Rockwood AL; Meikle WA; Homburg R; Lambalk CB
    Eur J Endocrinol; 2016 Jan; 174(1):25-32. PubMed ID: 26586837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: follow up data from the MiG trial.
    Battin MR; Obolonkin V; Rush E; Hague W; Coat S; Rowan J
    BMC Pediatr; 2015 May; 15():54. PubMed ID: 25943394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2012 May; (5):CD003053. PubMed ID: 22592687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months.
    Ijäs H; Vääräsmäki M; Saarela T; Keravuo R; Raudaskoski T
    BJOG; 2015 Jun; 122(7):994-1000. PubMed ID: 25039582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial.
    Alpañés M; Álvarez-Blasco F; Fernández-Durán E; Luque-Ramírez M; Escobar-Morreale HF
    Eur J Endocrinol; 2017 Nov; 177(5):399-408. PubMed ID: 28912358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of exercise and metformin treatment on circulating free DNA in pregnancy.
    Christiansen SC; Vanky E; Klungland H; Stafne SN; Mørkved S; Salvesen KÅ; Sæther M; Carlsen SM
    Placenta; 2014 Dec; 35(12):989-93. PubMed ID: 25282112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study.
    Glueck CJ; Phillips H; Cameron D; Sieve-Smith L; Wang P
    Fertil Steril; 2001 Jan; 75(1):46-52. PubMed ID: 11163815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropsychological assessment at school-age and prenatal low-level exposure to mercury through fish consumption in an Italian birth cohort living near a contaminated site.
    Deroma L; Parpinel M; Tognin V; Channoufi L; Tratnik J; Horvat M; Valent F; Barbone F
    Int J Hyg Environ Health; 2013 Jul; 216(4):486-93. PubMed ID: 23523155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Offspring body size and metabolic profile - effects of lifestyle intervention in obese pregnant women.
    Tanvig M
    Dan Med J; 2014 Jul; 61(7):B4893. PubMed ID: 25123127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Effect of Metformin Therapy for Preventing Gestational Diabetes Mellitus in Women with Polycystic Ovary Syndrome: A Meta-Analysis.
    Zhao J; Liu X; Zhang W
    Exp Clin Endocrinol Diabetes; 2020 Mar; 128(3):199-205. PubMed ID: 29890554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
    Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metformin use in obese mothers is associated with improved cardiovascular profile in the offspring.
    Panagiotopoulou O; Syngelaki A; Georgiopoulos G; Simpson J; Akolekar R; Shehata H; Nicolaides K; Charakida M
    Am J Obstet Gynecol; 2020 Aug; 223(2):246.e1-246.e10. PubMed ID: 32017923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial.
    Agarwal N; Rice SP; Bolusani H; Luzio SD; Dunseath G; Ludgate M; Rees DA
    J Clin Endocrinol Metab; 2010 Feb; 95(2):722-30. PubMed ID: 19996308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Metformin on IVF Outcomes in Overweight and Obese Women With Polycystic Ovary Syndrome: A Randomized Double-Blind Controlled Trial.
    Abdalmageed OS; Farghaly TA; Abdelaleem AA; Abdelmagied AE; Ali MK; Abbas AM
    Reprod Sci; 2019 Oct; 26(10):1336-1342. PubMed ID: 29576001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.